Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.6K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

211
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
211

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unexpected Cardiac Asystole Caused by Vasovagal Reaction During Venipuncture: A Case Report.

Clinical practice and cases in emergency medicine·2026
Same author

Delivering Cancer Care in Palestine: A Structured Situational Analysis from the Perspective of Oncology Nursing.

Seminars in oncology nursing·2026
Same author

Co-designing solutions to promote awareness of cervical screening with women of low socio-economic position living in urban areas.

BMC public health·2026
Same author

A Complex Diagnostic Challenge of Dual Antibiotic-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome With Multiorgan Involvement.

Cureus·2026
Same author

Collaborative Funding Model to Improve Quality of Care for Metastatic Breast Cancer in Europe.

Current oncology (Toronto, Ont.)·2025
Same author

Protocol for an umbrella review of the state-of-science on public and patient involvement in health and social care research with children, young people and families.

HRB open research·2025

Related Experiment Video

Updated: Apr 3, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K

Supporting patients receiving oral systemic anti-cancer therapies.

Amanda Drury1,2, Matthew Fowler3, Janice Richmond4

  • 1Trinity Centre for Practice & Healthcare Innovation, School of Nursing and Midwifery, Trinity College Dublin, Ireland.

Plos Medicine
|April 1, 2026
PubMed
Summary

Oral cancer therapies offer convenience but increase patient responsibility. Healthcare must adapt education, communication, and care models for safe and equitable oral anti-cancer treatment management.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K

Related Experiment Videos

Last Updated: Apr 3, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K

Area of Science:

  • Oncology
  • Pharmacology
  • Health Services Research

Background:

  • Oral systemic anti-cancer therapies (OSATs) are increasingly utilized, offering patient convenience.
  • The shift to oral medications transfers significant treatment management responsibilities to patients.
  • Current healthcare systems may not be fully equipped to support this transition.

Purpose of the Study:

  • To analyze the implications of increased patient responsibility in oral anti-cancer treatment.
  • To identify necessary adaptations in patient education, communication strategies, and care models.
  • To ensure safe, equitable, and sustainable delivery of oral anti-cancer therapies.

Main Methods:

  • Literature review on patient-centered care in oncology.
  • Analysis of current models for managing systemic anti-cancer treatments.
  • Qualitative assessment of patient and provider challenges with oral therapies.

Main Results:

  • OSATs necessitate enhanced patient self-management skills and adherence support.
  • Effective communication channels between patients and healthcare providers are crucial.
  • Existing care models require modification to address the unique demands of oral anti-cancer treatment.

Conclusions:

  • Adapting education, communication, and care models is essential for successful OSAT implementation.
  • Healthcare systems must evolve to support patients managing oral anti-cancer treatments safely and equitably.
  • Sustainable models of care are needed to optimize outcomes for patients receiving oral anti-cancer therapies.